Levetiracetam Noridem

Levetiracetam, the active ingredient in Levetiracetam Noridem, is an antiepileptic presented as an intravenous solution for intravenous use. It is employed to treat partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients who require rapid seizure control, often in hospital or emergency settings.

GNH USA supplies Levetiracetam Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levetiracetam is an antiepileptic medication used to control various seizure types.

- Partial seizures: reduces the frequency and severity of focal onset seizures, improving patient stability. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes and associated complications. - Myoclonic seizures: decreases the occurrence of sudden muscle jerks, aiding in overall seizure management.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or low in energy. - Somnolence: increased sleepiness or drowsiness. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe allergic reaction: includes rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare skin disorder with blistering. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Blood dyscrasias: abnormal blood cell counts, such as leukopenia.

When using Levetiracetam, several safety considerations are recommended.

- Renal function: assess and adjust dosing in patients with impaired kidney function. - Hepatic function: monitor liver enzymes, especially in patients with liver disease. - Concomitant CNS depressants: may increase sedation when used together. - Pregnancy: risk unknown; prescribe only if benefits outweigh potential risks. - Monitoring: observe for behavioral changes, mood swings, or depression. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenytoin: can reduce levetiracetam levels, diminishing seizure control. - Valproic acid: may increase levetiracetam concentrations, raising risk of side effects.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): may enhance sedation and respiratory depression. - Alcohol: can potentiate central nervous system effects, leading to increased drowsiness.